Parathyroid hormone‐related protein stimulates prostaglandin E2 release from human osteoblast‐like cells

Modulating effect of peptide length

Maryann Mitnick, Carlos M Isales, Indu Paliwal, Karl Insogna

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Parathyroid hormone‐related protein (PTHrP) is a potent bone‐resorbing protein that frequently mediates the humoral hypercalcemia of malignancy syndrome. Since prostaglandins may mediate the bone‐resorptive action of certain hormones, we examined the effect of PTHrP on prostaglandin E2 (PGE2) secretion by human osteoblast‐like cells. There was low‐level basal secretion of PGE2 by Saos‐2 cells (8.1 + 0.6 pg/ml). Using four different preparations of PTHrP, it was observed that with increasing peptide length, from 36 to 141 amino acids, a significant increase in efficacy for PGE2 release was seen in these cells. All forms of PTHrP were agonists for PGE2 release, with effects seen at concentrations as low as 10−12 M in 48 h conditioned media. The amino terminus of the molecule appeared critical for this effect since the truncated derivative PTHrP‐(7–34) did not induce significant PGE2 secretion. However, the influence of peptide length could not be explained by differential activation of adenylate cyclase since [Tyr26]PTHrP‐(1–36)amide was equipotent to the longest peptide preparation, PTHrP‐(1–141), in stimulating cyclic AMP accumulation in the Saos‐2 cells. In contrast, PTHrP‐(1–141) was significantly more effective than [Tyr35]PTHrP‐(1–36)‐amide in inducing a rise in cytosolic calcium. Further, this effect was noted at concentrations lower than those that caused significant cyclic AMP accumulation in the Saos‐2 cells. PTHrP‐(1–141) induced the release of PGE2 from primary human bone cell cultures to levels entirely comparable to those seen in the Saos‐2 cells. PTHrP‐(1–141) also induced PGE2 release by cultured fetal rat long bones at 72 h. We conclude that the carboxy‐terminal region of PTHrP has important effects on cellular signal transduction pathways and on the release of a potent bone‐active cytokine, PGE2.

Original languageEnglish (US)
Pages (from-to)887-896
Number of pages10
JournalJournal of Bone and Mineral Research
Volume7
Issue number8
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Dinoprostone
Peptides
Proteins
Amides
Cyclic AMP
Bone and Bones
Conditioned Culture Medium
Adenylyl Cyclases
Prostaglandins
Signal Transduction
Cell Culture Techniques
Hormones
Cytokines
Calcium
Amino Acids

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Parathyroid hormone‐related protein stimulates prostaglandin E2 release from human osteoblast‐like cells : Modulating effect of peptide length. / Mitnick, Maryann; Isales, Carlos M; Paliwal, Indu; Insogna, Karl.

In: Journal of Bone and Mineral Research, Vol. 7, No. 8, 01.01.1992, p. 887-896.

Research output: Contribution to journalArticle

@article{790bf840339348ed8f10a7b5adfb7d9c,
title = "Parathyroid hormone‐related protein stimulates prostaglandin E2 release from human osteoblast‐like cells: Modulating effect of peptide length",
abstract = "Parathyroid hormone‐related protein (PTHrP) is a potent bone‐resorbing protein that frequently mediates the humoral hypercalcemia of malignancy syndrome. Since prostaglandins may mediate the bone‐resorptive action of certain hormones, we examined the effect of PTHrP on prostaglandin E2 (PGE2) secretion by human osteoblast‐like cells. There was low‐level basal secretion of PGE2 by Saos‐2 cells (8.1 + 0.6 pg/ml). Using four different preparations of PTHrP, it was observed that with increasing peptide length, from 36 to 141 amino acids, a significant increase in efficacy for PGE2 release was seen in these cells. All forms of PTHrP were agonists for PGE2 release, with effects seen at concentrations as low as 10−12 M in 48 h conditioned media. The amino terminus of the molecule appeared critical for this effect since the truncated derivative PTHrP‐(7–34) did not induce significant PGE2 secretion. However, the influence of peptide length could not be explained by differential activation of adenylate cyclase since [Tyr26]PTHrP‐(1–36)amide was equipotent to the longest peptide preparation, PTHrP‐(1–141), in stimulating cyclic AMP accumulation in the Saos‐2 cells. In contrast, PTHrP‐(1–141) was significantly more effective than [Tyr35]PTHrP‐(1–36)‐amide in inducing a rise in cytosolic calcium. Further, this effect was noted at concentrations lower than those that caused significant cyclic AMP accumulation in the Saos‐2 cells. PTHrP‐(1–141) induced the release of PGE2 from primary human bone cell cultures to levels entirely comparable to those seen in the Saos‐2 cells. PTHrP‐(1–141) also induced PGE2 release by cultured fetal rat long bones at 72 h. We conclude that the carboxy‐terminal region of PTHrP has important effects on cellular signal transduction pathways and on the release of a potent bone‐active cytokine, PGE2.",
author = "Maryann Mitnick and Isales, {Carlos M} and Indu Paliwal and Karl Insogna",
year = "1992",
month = "1",
day = "1",
doi = "10.1002/jbmr.5650070805",
language = "English (US)",
volume = "7",
pages = "887--896",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Parathyroid hormone‐related protein stimulates prostaglandin E2 release from human osteoblast‐like cells

T2 - Modulating effect of peptide length

AU - Mitnick, Maryann

AU - Isales, Carlos M

AU - Paliwal, Indu

AU - Insogna, Karl

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Parathyroid hormone‐related protein (PTHrP) is a potent bone‐resorbing protein that frequently mediates the humoral hypercalcemia of malignancy syndrome. Since prostaglandins may mediate the bone‐resorptive action of certain hormones, we examined the effect of PTHrP on prostaglandin E2 (PGE2) secretion by human osteoblast‐like cells. There was low‐level basal secretion of PGE2 by Saos‐2 cells (8.1 + 0.6 pg/ml). Using four different preparations of PTHrP, it was observed that with increasing peptide length, from 36 to 141 amino acids, a significant increase in efficacy for PGE2 release was seen in these cells. All forms of PTHrP were agonists for PGE2 release, with effects seen at concentrations as low as 10−12 M in 48 h conditioned media. The amino terminus of the molecule appeared critical for this effect since the truncated derivative PTHrP‐(7–34) did not induce significant PGE2 secretion. However, the influence of peptide length could not be explained by differential activation of adenylate cyclase since [Tyr26]PTHrP‐(1–36)amide was equipotent to the longest peptide preparation, PTHrP‐(1–141), in stimulating cyclic AMP accumulation in the Saos‐2 cells. In contrast, PTHrP‐(1–141) was significantly more effective than [Tyr35]PTHrP‐(1–36)‐amide in inducing a rise in cytosolic calcium. Further, this effect was noted at concentrations lower than those that caused significant cyclic AMP accumulation in the Saos‐2 cells. PTHrP‐(1–141) induced the release of PGE2 from primary human bone cell cultures to levels entirely comparable to those seen in the Saos‐2 cells. PTHrP‐(1–141) also induced PGE2 release by cultured fetal rat long bones at 72 h. We conclude that the carboxy‐terminal region of PTHrP has important effects on cellular signal transduction pathways and on the release of a potent bone‐active cytokine, PGE2.

AB - Parathyroid hormone‐related protein (PTHrP) is a potent bone‐resorbing protein that frequently mediates the humoral hypercalcemia of malignancy syndrome. Since prostaglandins may mediate the bone‐resorptive action of certain hormones, we examined the effect of PTHrP on prostaglandin E2 (PGE2) secretion by human osteoblast‐like cells. There was low‐level basal secretion of PGE2 by Saos‐2 cells (8.1 + 0.6 pg/ml). Using four different preparations of PTHrP, it was observed that with increasing peptide length, from 36 to 141 amino acids, a significant increase in efficacy for PGE2 release was seen in these cells. All forms of PTHrP were agonists for PGE2 release, with effects seen at concentrations as low as 10−12 M in 48 h conditioned media. The amino terminus of the molecule appeared critical for this effect since the truncated derivative PTHrP‐(7–34) did not induce significant PGE2 secretion. However, the influence of peptide length could not be explained by differential activation of adenylate cyclase since [Tyr26]PTHrP‐(1–36)amide was equipotent to the longest peptide preparation, PTHrP‐(1–141), in stimulating cyclic AMP accumulation in the Saos‐2 cells. In contrast, PTHrP‐(1–141) was significantly more effective than [Tyr35]PTHrP‐(1–36)‐amide in inducing a rise in cytosolic calcium. Further, this effect was noted at concentrations lower than those that caused significant cyclic AMP accumulation in the Saos‐2 cells. PTHrP‐(1–141) induced the release of PGE2 from primary human bone cell cultures to levels entirely comparable to those seen in the Saos‐2 cells. PTHrP‐(1–141) also induced PGE2 release by cultured fetal rat long bones at 72 h. We conclude that the carboxy‐terminal region of PTHrP has important effects on cellular signal transduction pathways and on the release of a potent bone‐active cytokine, PGE2.

UR - http://www.scopus.com/inward/record.url?scp=0026756183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026756183&partnerID=8YFLogxK

U2 - 10.1002/jbmr.5650070805

DO - 10.1002/jbmr.5650070805

M3 - Article

VL - 7

SP - 887

EP - 896

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 8

ER -